How to choose a clinical trial EDC platform

Clinical trial analytics tools are not interchangeable the way the category name suggests. Some are the system of record that actually captures and manages a trial's data — the electronic data capture (EDC) and clinical data management systems (CDMS) that case report forms, randomization and query resolution run through. Others sit downstream of that: specialized services that capture one specific type of endpoint data, or analytics layers that speed up review of data someone else already collected. Knowing which of the three you need is the first decision, because the wrong category of tool cannot substitute for the right one.

You need an EDC/CDMS if you are a sponsor or CRO designing and running a trial and need somewhere to build case report forms, collect site data, and manage the study's operational lifecycle. You need an endpoint specialist if your protocol depends on centrally read imaging, patient-reported outcomes, or cardiac safety data that a general EDC isn't built to interpret. You need an analytics layer if your bottleneck is reviewing and cleaning data you're already capturing, not capturing it in the first place.

System of record, endpoint specialist, or analytics layer

Castor, Medidata, Oracle Clinical One and Veeva Vault CDMS are all systems of record: they are what a trial actually runs on. Clario is different in kind — it supplies centralized medical imaging, eCOA, cardiac safety and wearable-sensor data collection and interpretation, then feeds standardized results back into whichever EDC the sponsor is using. Saama is different again — it has no case report form builder of its own; it ingests data already captured by an EDC and other source systems and applies machine learning to flag anomalies and speed query resolution. Sponsors typically run Saama or Clario alongside one of the four EDC platforms, not instead of one.

Self-service or implementation-heavy

Among the four EDC/CDMS systems, Castor stands apart on how a study gets built. Its no-code, drag-and-drop study builder is designed for research teams to design case report forms and launch a study without heavy IT involvement — a real advantage for academic and investigator-initiated research and mid-size sponsors without a large clinical-systems team. Medidata, Oracle Clinical One and Veeva Vault CDMS are built for larger, more heavily supported implementations: multi-site, multi-country trials run by sponsors and CROs with dedicated clinical-data-management staff, typically with a longer study-build process involving more configuration and validation.

Existing platform standardization

If your organization already runs on a vendor's broader suite, that usually settles the question before features do. Oracle Clinical One is built to sit alongside other Oracle Health Sciences products, consolidating EDC, EHR data and reporting into one governed data model rather than requiring reconciliation between separate systems. Veeva Vault CDMS shares its underlying Vault metadata with Veeva's clinical operations (CTMS), eTMF and safety products, so a sponsor already standardized on Veeva Vault Clinical Suite gets EDC, coding and data cleaning inside the same environment its operations team already works in. If you have no existing platform commitment, this consideration disappears and the decision comes down to study complexity and support model instead.

What the system of record actually runs

Medidata is the broadest of the four: beyond Rave EDC, it bundles clinical trial management (CTMS), randomization and trial supply management (RTSM), safety data exchange, and patient-facing tools for decentralized and hybrid trial participation, all under one governed dataset with AI-assisted data-quality checks layered on top. Oracle Clinical One's distinguishing feature is a 2025-added AI-assisted connector that pulls structured and unstructured data directly from electronic health records into the platform. Veeva Vault CDMS's distinguishing feature is architectural — one application for EDC, coding and cleaning rather than three integrated tools. Castor bundles EDC with eCOA, eConsent and real-world-evidence data collection modules aimed at a leaner study team. Match the bundle to what your trial actually needs to run, not to the longest feature list.

Regulatory posture is table stakes, not a differentiator

All four EDC/CDMS platforms describe alignment with GCP, 21 CFR Part 11 and HIPAA-aligned controls; Castor additionally states ISO 27001 and ISO 9001 certification and GDPR alignment. Treat these as a minimum bar to confirm during due diligence rather than a basis for choosing between vendors — ask each one for its current audit and certification documentation rather than taking the marketing page at face value.

How pricing works

Every vendor in this category is quote-only, priced per study through direct negotiation. Castor is the one vendor whose own pricing page confirms the process is a custom quote through consultation, with no published tiers; the others simply don't publish pricing at all. Budget for the study-build and validation effort as a real cost alongside the license or subscription fee — it varies enormously between a no-code builder and a fully configured enterprise implementation.

Shortlist by situation

• If you run academic, investigator-initiated, or mid-size sponsor studies without a large clinical-systems team, look at Castor.
• If you need a single governed system spanning EDC, CTMS, RTSM and safety data for large regulated trials, look at Medidata.
• If you already run other Oracle Health Sciences products, look at Oracle Clinical One.
• If you're already standardized on Veeva's Vault Clinical Suite for operations or eTMF, look at Veeva Vault CDMS.
• If your protocol depends on centrally read imaging, eCOA or cardiac safety endpoints, look at Clario alongside your EDC.
• If your bottleneck is reviewing and cleaning data you already capture, look at Saama as a layer over your existing EDC.

Questions to ask vendors

• Is this system the actual system of record for our trial data, or does it sit downstream of one we still need to choose?
• What does study build and validation actually take, in weeks, for a protocol like ours?
• What current certifications and audit evidence can you provide for GCP, 21 CFR Part 11 and HIPAA-aligned handling?
• If we're already using [vendor X]'s other clinical systems, what is genuinely unified versus separately integrated?
• How does safety data flow from this system into our broader data governance and regulatory-submission processes?

Common mistakes

The most common mistake is evaluating an analytics layer like Saama against a full EDC like Medidata as if they compete — they solve different problems and are often bought together. A second is underestimating study-build time in an enterprise-heavy platform because a no-code competitor's demo set the expectation. A third is assuming AI-assisted quality-check or anomaly-detection features remove the need for human data review in a regulated trial; every vendor here positions these as acceleration, not replacement, for the query-resolution work a data manager still has to sign off on.

For more on the tools discussed here, read Medidata vs Veeva Vault CDMS and Medidata vs Oracle Clinical One, or browse every tool in this category.